Rosalyn Singleton MD MPH Alaska Native Tribal Health Consortium ;
|
|
- Hortense Cross
- 6 years ago
- Views:
Transcription
1 Rosalyn Singleton MD MPH Alaska Native Tribal Health Consortium ;
2 Why do research involving Alaska Native people? Lots of concerns Concerns about research Vulnerable at-risk population over-researched, feel like guinea pigs Potential for harm Reported alcoholism rates affected one region s application for grant funding Potential for genetic targeting bad genes?
3 Why research in Alaska Native people? To help eliminate health disparities In the 1970s Alaska Native people were found to have one of the highest reported rates of symptomatic hepatitis B in the U.S. Research into this disparity and hepatitis B vaccine led to an integrated hepatitis B immunization program Routine infant immunization and adult catch-up Hep B immunization has led to a decline in symptomatic Hep B infections from 250/100,000 to <0.5/100,000 Alaska Native people now have the lowest rate of Hep B infection of any racial group in the U.S.
4 Symptomatic Hepatitis B Incidence AK Native Persons Vaccine Demo Program begins in Yukon Kuskokwim Delta Statewide Program -newborn immunization
5 Incidence of Hepatitis A infections in Alaskans, Native and Non-Native, Rate per 100, Native Non-Native Year Singleton, McMahon, et al. Impact of vaccine program in Alaska VACCINE 2010;28:
6 Cases/100,000 Invasive Hib Disease, Children Aged <5 Years, Alaska, Native PRP-OMP PRP-OMP/HbOC DTwP-HbOC PRP-OMP Non-Native Year Singleton, et al. J Pediatr 2000; 137: and CDC, unpublished
7 However, research must adhere to the principles of the Belmont Report Justice Respect for Persons Beneficence Example from my experience: The Pneumo-13 Study
8 Rate per 100,000 Pneumococcal Disease, YK children <2 yrs, before Prevnar (PCV7) vaccine Invasive pneumococcal disease 10 times higher than non-native Alaskans. - Three-fourths caused by serotypes in PCV non-vaccine Vaccine type YK Children Other AK Native non-native Unpublished surveillance data AIP-CDC
9 Invasive Pneumococcal Disease Cases, YK Delta children <5 yrs, unk nonvaccine PCV A 19A 7F With routine PCV7 vaccine, pneumococcal disease rates initially declined dramatically. However, disease rates increased during due to non-vaccine serotypes But, Wyeth was finalizing studies for a 13 valent vaccine that covered ¾ of disease.
10 Rate per 100,000 Invasive Pneumococcal Disease Rates, Pre- and Post- PCV13, Children <5 years, Alaska % decrease in PCV13 disease 59 Pre Post (4/10-3/12) PCV13 Non-PCV13 PCV13 Non-PCV13 AK Native Non-Native
11 Justice Recruit participants fairly without discrimination, bias, or undue influence Distribute the benefits of research equitably Distribute the burdens of research fairly 11
12 Beneficence First, do no harm. Second, maximize possible benefits* and minimize possible harms. *Benefits to the participant associated with research participation as well as potential benefit to the community 13
13 Respect for Persons Individuals should be treated as autonomous agents. Individuals must not be coerced They must have adequate time to review and understand the informed consent and have all of their questions answered They must feel comfortable declining research Individuals with diminished autonomy are entitled to additional protections. 15
14 Respect for Community Tribal and village consultation takes time May need to meet with village councils Research includes local community members Expect face to face visits Travel to small villages Community members help set research priorities Discussion with tribal leaders may change proposal from placebo-controlled trial with greater chance to show effect, to a before and after trial which allows participants to benefit from the proposed intervention.
15 Example: 13-valent Pneumococcal Conjugate Study 1. We asked Wyeth to consider use of PCV-13 vaccine in YK children pre-licensure. 2. Wyeth agreed to sponsor a clinical trial in YK 3. The YKHC Board of Directors approved 4. We presented at the Tribal Gathering. Tribal elders voiced support. 5. The project was approved by Alaska Area IRB and ANTHC 6. Project Timeline: 1. Project Start: Jan Licensure: March 2010 (ended enrollment) 3. Last subject follow-up: Sept Study closure: Jan 27, 2011
16 What the Pneumo-13 Study involved We hired a YKHC study coordinator and 5 study nurses including 2 Alaska Natives We trained and certified ~50 health aides to recruit parents and administer study vaccine We shipped study vaccine under study regulations to YK and hand-carried vaccine to be stored in villages. Trained and certified nurses and health aides offered PCV-13 vaccine to eligible children Parents signed a voluntary informed consent. Children received PCV-13 vaccine on the same schedule as Prevnar 2, 4, 6, & 12 months. The project was voluntary. If parents declined PCV-13, their child received the licensed Prevnar vaccine.
17 Pneumo-13 study: Training and monitoring study staff and procedures YKHC village operations staff provided study training to study health aides Pfizer provided 2 day training on research procedures and protection of human studies to study personnel including health aides Pfizer study monitors visited Bethel monthly and reviewed all study documents and procedures An auditor came midway through the study and reviewed a sample of study documents and sites and procedures and vaccine storage
18 Pneumo-13 study : Study oversight The Principal Investigator (Ros) maintained daily contact with study personnel and had regular meetings with study health aides. PI traveled to Bethel ~ every 2 weeks to provide direct study oversight. PI teleconferenced with health aides and traveled to study villages to provide oversight PI reviewed all study documentation and all adverse event and answered questions from all study staff. PI met with other YKHC staff on a regular basis to answer questions and provide updates PI maintained approvals from Area and National IRBs, YKHC and individual study village tribal councils.
19 Pneumo-13 study: Protection of human subjects Adverse events monitored adverse events (including any hospitalizations or deaths for 6 months) were reported in all study participants A local study monitoring board met regularly and reviewed all adverse events reported in study participants The LSMB included YK community members and medical staff A Pfizer monitoring board reviewed all adverse events in study participants and reported to the FDA
20 Study-related Personnel Yukon Kuskokwim Health Corporation Jane Russell, Village Operations co-investigator Chris Desnoyers study coordinator Dr. Ellen Hodges co-investigator Dr. Jane McClure co-investigator Dr. Carolyn Lorenz co-investigator (moved) Christine Wiscombe research nurse (moved) Allison Samuelson research nurse Robin Gosney Data Manager Supervisor Kerry Cobbledick/Peggy Byrd research nurses Bessie Francis study data manager (new job) Dr. Joe Klejka, Medical Director Safety Monitoring Committee Numerous Health Aides and Providers Debbie Michael and Maxine Brink Safety Monitoring Comm Alaska Native Tribal Health Consortium Dr. Rosalyn Singleton, - Principal Investigator Arctic Investigations Program CDC Dr. Jay Wenger Safety Monitoring Committee Dana Bruden, statistician Safety Monitoring Committee Pfizer Vaccine Research and Development Dr. Daniel Scott Asst. VP, Pfizer Vaccine Clinical Research Dr. Allison Thompson Associate Director, Pfizer Vaccine Clinical Research David Reyes, and others 24
21 Why Have an Institutional Review Board To protect research participants To encourage health research To receive federal funds
22 Alaska is divided into regional tribal health organizations located in geographic regions that feed into 6 tribal health hubs
23 IHS IRB: The Two-Tier System National IHS IRB Area IHS IRBs: Aberdeen Alaska Albuquerque Bemidji Billings California Nashville Navajo Oklahoma Phoenix Portland Tucson Francine Romero, MPH, PhD
24 Criteria for Review of Research Risks to participants are minimized Selection is equitable Informed consent will be obtained Informed consent will be sought Risks are reasonable in relation to anticipated benefits
25 Research plan makes adequate provisions for monitoring safety Tribal Review of Research Additional safeguards for participants likely to be vulnerable to coercion or undue influence Adequate provisions to protect privacy and maintain confidentiality Waiver of consent obtained
26
27 IRB: Gate Keeper of the Belmont Principles Investigators should not have sole responsibility for determining whether research involving human subjects fulfills ethical standards. Others who are independent of the research must share this responsibility. National Commission Report on Institutional Review Boards, 1978
28 Benefits of Ethical Research Review Review by participants can reduce risk and increase benefits Consent becomes a process not a signature Research can be more relevant to the participants Research is respectful of cultural guidelines Researchers can develop long term trust relationships Research can be enhanced and useful to the participants
29 Obligation to report research findings Report findings first to the study population (tribal health organization Report Pneumo-13 results at Tribal Gathering and at YKDRH Grand Rounds Obtain regional and Alaska Area tribal approval for any publication of results. PCV13 paper just printed in PIDJ
30 Research Involving Specimens March 2007 PRIM&R white paper The Stored Tissue Issue- Weir/Olick National Institutes of Medicine - report on Tissue Samples in the Laboratory The Indian Health Service Specimen Protocol The Alaska Area Specimen Banking Protocol 43
31 Summary Research involving Alaska Native people can help to further knowledge on ways to eliminate health inequities. Research must have community input and be approved by the community and regional tribal org. Research ideas should be shared and discussed early with community leaders and results must be shared Research should be conducted in concert with the tribal organization and, if possible, employ community members
Impact of Vaccines on Alaska Native Health MCH Immunization Conference Sept 22, 2008
Impact of Vaccines on Alaska Native Health MCH Immunization Conference Sept 22, 2008 Rosalyn Singleton MD MPH Alaska Native Tribal Health Consortium ris2@cdc.gov 729-3418 Vaccine-Preventable Disease in
More informationCohort Study of Antibody Levels in a Yupik Eskimo Population 30 Years after Hepatitis B Vaccine Vax Demo 30
Cohort Study of Antibody Levels in a Yupik Eskimo Population 30 Years after Hepatitis B Vaccine Vax Demo 30 Michael Bruce MD MPH Arctic Investigations Program Anchorage, Alaska Centers for Disease Control
More informationOral Health Surveillance in the Yukon-Kuskokwim Delta. Timothy K. Thomas, MD Gretchen Day, MPH Jonathan Newman, MPH Dane Lenaker, DMD, MPH
Oral Health Surveillance in the Yukon-Kuskokwim Delta Timothy K. Thomas, MD Gretchen Day, MPH Jonathan Newman, MPH Dane Lenaker, DMD, MPH Background 2008 Yukon Kuskokwim Health Corporation (YKHC) requested
More informationMeasles Elimination: Successes and Challenges in Alaska
Measles Elimination: Successes and Challenges in Alaska Rosalyn Singleton, MD, MPH State of Alaska, Section Epidemiology & Alaska Native Tribal Health Consortium www.nwcphp.org/hot-topics Measles in the
More informationREQUIRED INSTITUTIONAL REVIEW BOARD (IRB) EDUCATIONAL READING FOR FLETCHER SCHOOL RESEARCHERS APPLYING FOR EXEMPTION FROM IRB
REQUIRED INSTITUTIONAL REVIEW BOARD (IRB) EDUCATIONAL READING FOR FLETCHER SCHOOL RESEARCHERS APPLYING FOR EXEMPTION FROM IRB Please read the following text, adapted from the CITI Education Module (Braunschweiger,
More informationUsing electronic dental records to monitor caries prevalence in Alaska Native children
Using electronic dental records to monitor caries prevalence in Alaska Native children Tom Hennessy, MD, MPH Director, CDC Arctic Investigations Program National Center for Emerging and Zoonotic Infectious
More informationImpacto de la vacuna conjugada en EUA
Impacto de la vacuna conjugada en EUA Richard Facklam, PhD, Distinguished Consultant, Retired, Centers for Disease Control and Prevention Atlanta, GA Bogotá, Colombia, February 2008 Pneumococcal Conjugate
More informationImpact of pneumococcal conjugate vaccine: US experience Stephanie Schrag Centers for Disease Control and Prevention Atlanta, GA
Impact of pneumococcal conjugate vaccine: US experience Stephanie Schrag Centers for Disease Control and Prevention Atlanta, GA San Jose, Costa Rica, August 2007 Pneumococcal Conjugate Vaccine Introduction
More informationSecond World Indigenous Peoples' Conference on Viral Hepatitis
Second World Indigenous Peoples' Conference on Viral Hepatitis Individual response report Respondent Anonymous Type: : Email: IP : 158.145.224.111 Country: United s Custom Data 1: Custom Data 2: Custom
More informationRecommended Childhood Immunization Schedu...ates, January - December 2000, NP Central
Recommended Childhood Immunization Schedule United States, January - December 2000 Vaccines 1 are listed under routinely recommended ages. Solid-colored bars indicate range of recommended ages for immunization.
More informationWhy is surveillance important after introducing vaccines?
Why is surveillance important after introducing vaccines? Dr Michael Edelstein Immunisation Department, National Infections service Public Health England @epi_michael BSAC Spring conference, 12 th March
More informationImpact of American Indian Research on Global Health
Impact of American Indian Research on Global Health Kate O Brien on behalf of Center for American Indian Health Department of International Health Johns Hopkins Bloomberg School of Public Health October
More informationSurveillance for Hepatitis A in Alaska; the impact of childhood vaccination program
Surveillance for Hepatitis A in Alaska; the impact of childhood vaccination program Liver Disease and Hepatitis Program Alaska Native Tribal Health Consortium Ref: R Singleton et al. Impact of a statewide
More informationRisk Factors for Lower Respiratory Tract Infections in Young Children
Risk Factors for Lower Respiratory Tract Infections in Young Children Thomas Hennessy, MD, MPH CDC Arctic Investigations Program Anchorage, Alaska tbh0@cdc.gov. Why focus on risk factors? Southwest Alaska
More informationInfluenza Vaccination of Health-care Personnel: A Department of Health and Human Services Initiative
Influenza Vaccination of Health-care Personnel: A Department of Health and Human Services Initiative Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human Services 1 Major
More informationInstitutional Review Boards and Human Subjects Protection
Institutional Review Boards and Human Subjects Protection Professor Ron Fricker! Naval Postgraduate School! Monterey, California! 6/25/12 1 Goals for this Lecture! A nasty little bit of history! The Belmont
More informationAmerican Indian Public Health: An Emerging Discipline
American Indian Public Health: An Emerging Discipline Pathways Into Health October 11, 2012 Donald Warne, MD, MPH Oglala Lakota Director, Master of Public Health Program North Dakota State University OVERVIEW
More informationPreventive Care ALASKA NATIVE HEALTH STATUS REPORT 13
Preventive Care ALASKA NATIVE HEALTH STATUS REPORT 13 14 ALASKA NATIVE HEALTH STATUS REPORT Highlights Approximately half (56.5%) of Alaska Native adults received dental care in the past year. Approximately
More informationUniversity of Ghana. Research Ethics Policy
University of Ghana Research Ethics Policy March, 2013 Table of Content 1. Purpose of Policy 3 2. Aims 3 3. Key Definitions.4 4. Scope of Policy.5 5. Basic Ethical Principles..5 6. Institutional Authority
More informationInstitutional Review of Research Involving Human Participants. IRB Presentation. University of Central Florida Office of Research & Commercialization
Institutional Review of Research Involving Human Participants IRB Presentation University of Central Florida Office of Research & Commercialization 407-823-2901 or fax 407-823-3299 www.research.ucf.edu/compliance/irb.html
More informationCarga global de la enfermedad neumocócia
Carga global de la enfermedad neumocócia Ann R. Thomas, MD MPH Public Health Division Portland, Oregon Caracas, Venezuela, January 2008 Acknowledgements to Adam Cohen, CDC Principales Causas de Muertes
More informationIRB Reviewer Worksheet for Expedited Reviews
IRB Reviewer Worksheet for Expedited Reviews This reviewer worksheet is copied with modifications from Khan and Kornetsky s Overview of Initial Protocol Review printed in IRB Management and Function (2006).
More informationResearch Involving Human Subjects: Ethics, Process, and Guidance for Streamlining IRB Review
Research Involving Human Subjects: Ethics, Process, and Guidance for Streamlining IRB Review Graduate Medical Education October 9, 2013 Cortni Romaine Education and Outreach Coordinator Office of Human
More information21 st Century Vaccine Challenges
21 st Century Vaccine Challenges Presentation by Rosalyn Singleton MD, ANTHC Slides adapted from original powerpoint by: Carrie L. Byington, MD HA and Edna Benning Presidential Professor of Pediatrics
More informationIRB Review Points to Consider September 2016
POINTS TO CONSIDER Principal investigators 1. Does the principal investigator have the appropriate qualifications, experience, and facilities to ensure that all aspects of the project and follow-up will
More informationVACCINES FOR ALASKANS: ALASKA VACCINE ASSESSMENT PROGRAM
VACCINES FOR ALASKANS: ALASKA VACCINE ASSESSMENT PROGRAM MCH-Immunization Conference September 24, 2014 Joe McLaughlin MD, MPH Rosalyn Singleton MD Gerri Yett RN, MSN, CHES Alaska Section of Epidemiology
More informationGuidelines for Ethical Conduct of Behavioral Projects Involving Human Participants by High School Students
Guidelines for Ethical Conduct of Behavioral Projects Involving Human Participants by High School Students Introduction Improving science literacy in the United States requires strengthening science, technology,
More informationModule: History and Ethical Principles ( )
Module: History and Ethical Principles (7-18-11) Concepts of research ethics: Provide us with a structure for analysis and decision-making. Support and remind researchers to protect human subjects. Provide
More informationTITLE: Polychlorinated Biphenyls, Organochlorines & PD Risk: A Case Control Study in Alaska
AD Award Number: W81XWH-04-1-0490 TITLE: : A Case Control Study in Alaska PRINCIPAL INVESTIGATOR: CONTRACTING ORGANIZATION: The Parkinson s Institute Sunnyvale, CA 94085 REPORT DATE: Annual TYPE OF REPORT:
More informationInvasive Bacterial Diseases in the Arctic. Tom Hennessy, MD, MPH Arctic Investigations Program October 2, 2015 Copenhagen
Invasive Bacterial Diseases in the Arctic Tom Hennessy, MD, MPH Arctic Investigations Program October 2, 2015 Copenhagen Outline Introduction to Alaska International Circumpolar Surveillance Invasive bacterial
More informationProtecting Human Subjects In Social-Behavioral-Educational Research:
Protecting Human Subjects In Social-Behavioral-Educational Research: Working with the IRB Lloyd Byrd, MS Chair, VCU IRB Panel E Member, VCU IRB Panel B Monika S. Markowitz, Ph.D. Director, Office of Research
More informationTo view past issues, go to: The New 13-Valent Pneumococcal Conjugate Vaccine (PCV13)
From the Texas Department of State Health Services Immunization Branch The goal of the Vaccine Advisory is to disseminate, in a timely manner, practical information related to vaccines, vaccine-preventable
More informationMarie Stopes International Informed Consent Guidelines for Research
Marie Stopes International Informed Consent Guidelines for Research Developed by: Research, Monitoring, and Evaluation Team Health System Department, MSI Marie Stopes International Informed Consent Guidelines
More informationIRB GRAND ROUNDS SOCIAL AND BEHAVIORAL RESEARCH: NEED TO KNOW
IRB GRAND ROUNDS SOCIAL AND BEHAVIORAL RESEARCH: NEED TO KNOW Vivienne Carrasco, MPH,CIP Senior IRB Regulatory Analyst, Social and Behavioral Sciences Human Subject Research Office University of Miami
More informationCarga global de la enfermedad neumocócia Adam L. Cohen, MD MPH Centers for Disease Control and Prevention Atlanta, GA
Carga global de la enfermedad neumocócia Adam L. Cohen, MD MPH Centers for Disease Control and Prevention Atlanta, GA Santiago, Chile, December 2007 Pneumococcal Carriage and Disease Ear infections Meningitis
More informationIRB for Humanists. Naomi E. Coll, MPH, CPH, CIP Manager of Research Integrity
IRB for Humanists Naomi E. Coll, MPH, CPH, CIP Manager of Research Integrity Grace Caskie, Ph.D. Associate Professor Counseling Psychology IRB co-chair Patti Manz, Ph.D. Associate Professor School Psychology
More informationSuccesses & Lessons Learned from the Diabetes Prevention Program & Health Heart Project
SPECIAL DIABETES PROGRAM FOR INDIANS Successes & Lessons Learned from the Diabetes Prevention Program & Health Heart Project Jenn Russell, MHA SDPI Initiatives Coordinating Center Centers for American
More informationFlexibility and Informed Consent Process
Flexibility and Informed Consent Process April 30, 2014 Regulatory & Ethical Requirements for Informed Consent Megan Kasimatis Singleton, JD, MBE, CIP Associate Director, IRB Dave Heagerty IRB 8 Coordinator
More informationManagement of Patients with Chronic Hepatitis B: The Alaska Experience
Management of Patients with Chronic Hepatitis B: The Alaska Experience Brian J McMahon, MACP, FAASLD Liver Disease and Hepatitis Program Alaska Native Tribal Health Consortium Disclosures I have no conflicts
More informationHuman Research Protection Program Institutional Review Board Procedure
Page 1 of 10 DESCRIPTION INSTITUTIONAL REVIEW BOARD REVIEW OF RESEARCH INVOLVING PRISONERS Prisoners may be under constraints because of their incarceration that could affect their ability to make a truly
More informationIRB, IDEATE, AND HSR. February, 2018 Manuel Gonzalez
IRB, IDEATE, AND HSR February, 2018 Manuel Gonzalez Outline What is the IRB? Human Subjects Research and Researcher Responsibilities Citi Certification Ethical Principles Revisions etc. Submitting Studies
More informationUpdates on H. pylori research in Alaska. Bethel, Alaska, July 26 th 2016 Michael Bruce MD, MPH AIP/CDC, Anchorage, Alaska
Updates on H. pylori research in Alaska Bethel, Alaska, July 26 th 2016 Michael Bruce MD, MPH AIP/CDC, Anchorage, Alaska H. pylori Epi Background Organism: helical-shaped gram negative rod Reservoir: Humans
More informationResearch Ethics: A Brief Introduction. February 2017 Dina Shafey, Associate Director, ORE
Research Ethics: A Brief Introduction February 2017 Dina Shafey, Associate Director, ORE dshafey@sfu.ca Why Does Research Ethics Matter? Tuskegee syphilis experiment 1932-1972 Objectives Apply the three
More informationTENNESSEE STATE UNIVERSITY HUMAN SUBJECTS COMMITTEE
TENNESSEE STATE UNIVERSITY HUMAN SUBJECTS COMMITTEE RESEARCH PROPOSAL FORM This proposal is: (check where applicable) Dissertation Research: Grant Proposal: Funding Agency: Master's Thesis Research: Faculty
More informationIRB FREQUENTLY ASKED QUESTIONS. 1. Who must apply for human subjects review through the IRB (Institutional Research Board)?
IRB FREQUENTLY ASKED QUESTIONS 1. Who must apply for human subjects review through the IRB (Institutional Research Board)? All Regis University faculty, students (graduate and undergraduate), and staff
More informationNational Vaccine Plan: From Strategy to Implementation
National Vaccine Plan: From Strategy to Implementation July 26, 2011 Sarah Landry Senior Advisor, National Vaccine Program Office Office of the Assistant Secretary for Health Department of Health and Human
More informationCHRONIC HEPATITIS B AND C COHORT STUDY (CHECS)
CHRONIC HEPATITIS B AND C COHORT STUDY (CHECS) CDC CONTACT Scott D Holmberg, M.D., M.P.H. Chief, Epidemiology and Surveillance Branch Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis,
More informationPneumococcal disease: Global burden, epidemiology, scope for vaccine prevention
Pneumococcal disease: Global burden, epidemiology, scope for vaccine prevention Stephanie Schrag Centers for Disease Control and Prevention Atlanta, GA San Jose, Costa Rica, August 2007 Pneumococcal Carriage
More informationMEDICAL ASSISTANCE BULLETIN
ISSUE DATE August 30, 2010 EFFECTIVE DATE August 30, 2010 MEDICAL ASSISTANCE BULLETIN NUMBER 01-10-27, 08-10-28, 09-10-29, 31-10-30, 33-10-05 SUBJECT: Updates to the Medical Assistance Program Fee Schedule
More informationSpecial Diabetes Program for Indians
Special Diabetes Program for Indians Ann Bullock, MD Carmen Hardin, MSN, APRN Division of Diabetes Treatment and Prevention Office of Clinical and Preventive Services Indian Health Service Special Diabetes
More informationBCG vaccine and tuberculosis
PART 2: Vaccination for special risk groups 2.1 Vaccination for Aboriginal and Torres Strait Islander people Aboriginal and Torres Strait Islander people historically had a very high burden of infectious
More informationChanges for the School Year
February 8, 2018 Dear Immunization Provider: In accordance with South Carolina Code of Laws, Section 44-29-180, and South Carolina Regulation 61-8, the 2017-2018 "Required Standards of Immunization for
More informationDHAT Issues in Indian Country
DHAT Issues in Indian Country Christina Peters Native Dental Therapy Initiative Project Director Northwest Portland Area Indian Health Board Oklahoma City, OK 1:30-3:00pm Sept 18, 2018 BUILDING A 21 ST
More informationImpact of In-home Piped Water on Rates of Infectious Disease - The Four Village Study
Impact of In-home Piped Water on Rates of Infectious Disease - The Four Village Study Water and Health October, 2016 Timothy Thomas: ANTHC Troy Ritter: ANTHC Dana Bruden: CDC/AIP Mike Bruce: CDC/AIP Korie
More informationUse of 13-valent Pneumococcal Conjugate Vaccine and 23-valent Polysaccharide Vaccine in Adults with Immunocompromising Conditions
Use of 13-valent Pneumococcal Conjugate Vaccine and 23-valent Polysaccharide Vaccine in Adults with Immunocompromising Conditions Tamara Pilishvili, MPH Respiratory Diseases Branch National Center for
More informationWorld Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects
Ethical Principles for Medical Research Involving Human Subjects Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964, and amended by the: 29th WMA General Assembly, Tokyo, Japan, October
More informationNorthwestern University. Consent Form and HIPAA Authorization for Research
Northwestern University Consent Form and HIPAA Authorization for Research PROTOCOL TITLE: Yoga Versus Resistance Training in Parkinson s Disease: A Randomized, Controlled Pilot Study of Feasibility & Efficacy
More informationAmerican Indian Health Equity: Impact of Historical Trauma and ACEs on Health Disparities. University on New Mexico April 5, 2018
American Indian Health Equity: Impact of Historical Trauma and ACEs on Health Disparities University on New Mexico April 5, 2018 Donald Warne, MD, MPH Oglala Lakota Chair, Department of Public Health North
More informationMCH-Immunization Conference. September 2012
MCH-Immunization Conference September 2012 Rosalyn Singleton MD Arctic Investigations Program-CDC Alaska Native Tribal Health Consortium, Anchorage, AK DISCLAIMER: The results and conclusions presented
More informationErrata Corrected 17 January, 2017
Errata Corrected 17 January, 2017 Previously, colorectal cancer was erroneously omitted as the second leading cancer, by frequency, among Alaska Native Women in the Interior Tribal Health Region from 1984
More informationDaniel T Lackland. Medical University of South Carolina
Daniel T Lackland Medical University of South Carolina Many ethical concerns must be addressed when research involves human participates. People will accept risks and inconvenience with research that leads
More informationHuman Research Ethics Committee. Some Background on Human Research Ethics
Human Research Ethics Committee Some Background on Human Research Ethics HREC Document No: 2 Approved by the UCD Research Ethics Committee on February 28 th 2008 HREC Doc 2 1 Research Involving Human Subjects
More information1. What is your role in the AAHRPP accreditation process?
Investigator Responsibilities AAHRPP accreditation is a gold standard recognizing adherence to a rigorous set of human subjects protection standards that go beyond federal and state requirements. It communicates
More informationMore Changes! VFC Program Recommendations and Requirements
More Changes! 2014-2015 VFC Program Maribel Chavez-Torres, MPH Immunization Program Director City of Chicago Mayor Rahm Emanuel Chicago Department of Public Health Commissioner Bechara Choucair, M.D. VFC
More informationETHICS IN CLINCAL RESEARCH A HISTORY OF HUMAN SUBJECT PROTECTIONS AND PRACTICAL IMPLEMENTATION OF ETHICAL STANDARDS
ETHICS IN CLINCAL RESEARCH A HISTORY OF HUMAN SUBJECT PROTECTIONS AND PRACTICAL IMPLEMENTATION OF ETHICAL STANDARDS David Perlman, Ph.D. Senior Education Advisor Glaxo Smith Kline Adjunct Assistant Professor
More informationSUBJECT: SJMHS Institutional Review Board(s): Vulnerable Populations - Research Involving Prisoners
MANUAL: Administrative Policy & Procedure Manual SJMHS Locations: St. Joseph Mercy Ann Arbor, St. Joseph Mercy Chelsea, St. Joseph Mercy Livingston, St. Mary Mercy Livonia POLICY: Persons meeting the federal
More informationIOM Committee on Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule
IOM Committee on Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule Bruce Gellin, MD, MPH Director, National Vaccine Program Office Deputy Assistant Secretary
More informationHaemophilus influenzae
Haemophilus influenzae type b Severe bacterial infection, particularly among infants During late 19th century believed to cause influenza Immunology and microbiology clarified in 1930s Haemophilus influenzae
More informationChanges for the School Year. The addition of NINTH grade to the requirement for four (4) doses of diphtheria, tetanus, and pertussis.
February 19, 2013 Dear Immunization Provider: In accordance with South Carolina Code of Laws, Section 44-29-180, and State Regulation 61-8, the 2013-2014 "Required Standards of Immunization for School
More informationPART 1: INTRODUCTION AND OVERVIEW
PART 1: INTRODUCTION AND OVERVIEW GATEKEEPER TRAINING SUICIDE PREVENTION TRAINING/THE QPR APPROACH 2013 IMPORTANCE OF EVALUATION Provides valuable information: Usefulness of the trainings. Suggestions
More informationThe Partnership for Native American Cancer Prevention (U54)
The Partnership for Native American Cancer Prevention (U54) David S. Alberts, MD - Principal Investigator, AZCC/UA Laura Foster Huenneke, PhD - Principal Investigator, NAU Jesse Martinez, PhD - Research
More informationUNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM
Gilead Sciences, Inc. GS-US-337-0115, 25-NOV-2013 A Phase 3, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination for 12 Weeks in Subjects
More informationTHE ORAL HEALTH OF AMERICAN INDIAN AND ALASKA NATIVE ADULT DENTAL PATIENTS: RESULTS OF THE 2015 IHS ORAL HEALTH SURVEY
THE ORAL HEALTH OF AMERICAN INDIAN AND ALASKA NATIVE ADULT DENTAL PATIENTS: RESULTS OF THE 2015 IHS ORAL HEALTH SURVEY Kathy R. Phipps, Dr.P.H. and Timothy L. Ricks, D.M.D., M.P.H. KEY FINDINGS 1. AI/AN
More informationApplication Deadline: Open Until Filled
Vacancy Announcement Title: Reports to: Location: Salary: Summary: Clinic Dentist Dental Director Yreka Dental Clinic Depends on Experience The Clinic Dentist is responsible to treat clinic patients within
More information*Explain the purpose & role of the IRB *Explain the IRB Review Categories *Discuss the potential risks to research participants
Explain the purpose & role of the IRB Explain the IRB Review Categories Discuss the potential risks to research participants Discuss the informed consent process Review the IRB Submission Process The Institutional
More informationHUMAN PAPILLOMAVIRUS (HPV) VACCINE IMPACT AND ALASKA RESEARCH
HUMAN PAPILLOMAVIRUS (HPV) VACCINE IMPACT AND ALASKA RESEARCH MCH Immunization Conference September 24, 2014 Thomas Hennessy MD Arctic Investigations Program CDC Rosalyn Singleton MD State of Alaska Epidemiology;
More informationPrograms for Chronic HBV and HCV in Alaska Natives
Programs for Chronic HBV and HCV in Alaska Natives Brian J McMahon MD, Liver Disease and Hepatitis Program Alaska Native Medical Center and Arctic Investigations Program, CDC Misconceptions about Alaska
More informationEthics. A Little History. The Nuremberg Doctors Trial of From Belmont Report
Ethics From Belmont Report A Little History It is important to look at history We learn from our mistakes History can repeat itself! The Nuremberg Doctors Trial of 1946 The Milgram Study Thalidomide Tragedy
More informationCOMMUNITY RESEARCH WORKSHOP
COMMUNITY RESEARCH WORKSHOP Community Research Workshop Activity: Opinions & Attitudes Source: Family Health International, 2004 Tree Metaphor The tree symbolizes strength, healing and fruitfulness in
More informationAlaska Native Injury Atlas of Mortality and Morbidity. Prepared by: The Injury Prevention Program and the Alaska Native Epidemiology Center
Alaska Native Injury Atlas of Mortality and Morbidity Prepared by: The Injury Prevention Program and the Alaska Native Epidemiology Center Alaska Native Tribal Health Consortium January 2008 Acknowledgements
More informationHSPC/IRB Description of Research Form (For research projects involving human participants)
HSPC/IRB Description of Research Form (For research projects involving human participants) This form is to be completed by the Principal Investigator (P.I.) of the research project being submitted to the
More informationMDCH IRB REVIEW APPLICATION Authority: Code of Federal Regulations Title 45 Part 46
The Michigan Department of Community Health Institutional Review Board for the Protection of Human Research Subjects Capitol View Building, 7 th Floor, 201 Townsend Street, Lansing, MI 48913 Phone: 517/241-1928
More informationInformed Consent Procedures and Writing Informed Consent Forms
STANDARD OPERATING PROCEDURE Informed Consent Procedures and Writing Informed Consent Forms Standard Operating Procedure Western Health SOP reference 006 Version: 2.0 dated December 2015 Effective Date
More informationACIP Recommendations for Pneumococcal 13-valent Conjugate and 23-valent Polysaccharide Vaccine Use among Adults
ACIP Recommendations for Pneumococcal 13-valent Conjugate and 23-valent Polysaccharide Vaccine Use among Adults National Center for Immunization & Respiratory Diseases Respiratory Diseases Branch ACIP
More informationINSTITUTIONAL REVIEW BOARD
INSTITUTIONAL REVIEW BOARD Policies and Definitions promotes and supports human research. Basic tenets of human research are voluntary participation and the ethical treatment of the subjects in the research
More informationImpact of Unresolved Trauma on American Indian Health. Avera Health Sioux Falls, SD May 7, 2018
Impact of Unresolved Trauma on American Indian Health Avera Health Sioux Falls, SD May 7, 2018 Donald Warne, MD, MPH Oglala Lakota Associate Dean, Diversity, Equity and Inclusion Director, INMED UND School
More informationSummary of Changes to Human Subjects Regulations: Effective January 21, 2019
Summary of Changes to Human Subjects Regulations: Effective January 21, 2019 The New Human Subjects Regulations - What does it all mean? This guide serves to assist Clemson University researchers to understand
More informationNational Comprehensive Cancer Control Program Reviewer Training March 16, 2017
FOA DP17-1701 Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations National Comprehensive Cancer Control Program Reviewer Training March 16, 2017 Angela Moore, MPH, Team
More informationDeployment of Combination Vaccines and STI vaccines
Deployment of Combination Vaccines and STI vaccines Advancing Prevention Technologies for Sexual and Reproductive Health Symposium Berkeley, Ca March 24, 2009 Eileen Yamada, MD, MPH California Department
More informationUncertainty with and timing of funding with next CDC FOA. Collaboration
Table 2: Summary of overarching policy, systems and environmental priorities and planned action steps during the summit and reported stages of change, successes and challenges six months later by Region
More informationDenise Middlebrook, PhD Community Intervention Director Kauffman & Associates, Inc.
Denise Middlebrook, PhD Community Intervention Director Kauffman & Associates, Inc. Trauma in AI/AN Communities Cultural l What broke our world apart (Gathering of Native Americans) Historical long term
More informationUNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM
IRC 004, Version 5, July 31, 2013 A Randomized Double-Blind Study Comparing Oseltamivir versus Placebo for the Treatment of Influenza in Low Risk Adults CONSENT TO PARTICIPATE IN A RESEARCH STUDY AND RESEARCH
More informationNEAM NEWS THE NICOTINE EXPOSURE AND METABOLISM STUDY NEWSLETTER
NEAM NEWS THE NICOTINE EXPOSURE AND METABOLISM STUDY NEWSLETTER Issue 1: Introduction MONTHLY REPORTS TO THE COMMUNITY ABOUT THE NEAM STUDY FINDINGS Dear Community Members, I am pleased to send you the
More informationImmunization Program. Directors of Licensed Child Day Care Centers & Group Day Care Homes. FROM: Mick Bolduc-Epidemiologist Debra L.
Immunization Program TO: Directors of Licensed Child Day Care Centers & Group Day Care Homes FROM: Mick Bolduc-Epidemiologist Debra L. Johnson-Chief Immunization Program Community Based Regulation Section
More informationSTIs in Native American Populations: Changing the Story
STIs in Native American Populations: Changing the Story Jill Huppert, MD MPH Chief, Program Development and Quality Improvement Division of STD Prevention Center for Disease Control and Prevention 6 th
More informationGive Birth to the End of Hepatitis B
Give Birth to the End of Hepatitis B LiverConnects Feb 14, 2017 Rosalyn Singleton MD MPH Research Physician, ANTHC ris2@cdc.gov risingleton@anthc.org Annie Peterson-Lewis RN State of Alaska Perinatal Hepatitis
More informationBAPTIST HEALTH SOUTH FLORIDA INSTITUTIONAL REVIEW BOARD INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING HUMAN SUBJECT RESEARCH
BAPTIST HEALTH SOUTH FLORIDA INSTITUTIONAL REVIEW BOARD INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING HUMAN SUBJECT RESEARCH Original Release Date: November 2011 Course Expiration Date: November 2014 Overview:
More informationMark H. Sawyer, MD Professor of Clinical Pediatrics UCSD School of Medicine and Rady Children s Hospital San Diego
Mark H. Sawyer, MD Professor of Clinical Pediatrics UCSD School of Medicine and Rady Children s Hospital San Diego I have no relevant financial relationships with the manufacturer(s) of any commercial
More informationVFC NEW PROVIDER ENROLLMENT FOR PEDIATRIC SITE
New Jersey Department of Health Vaccines for Children (NJVFC) Program P.O. Box 369 Trenton, NJ 08625-0369 Phone: (609) 826-4862 Fax: (609) 826-4868 INSTRUCTIONS: Email the completed VFC New Provider Enrollment
More informationThe Chronic Hepatitis Cohort Study ( CHeCS )
The Chronic Hepatitis Cohort Study ( CHeCS ) Overview of a model of cooperation between external partners, CDC Foundation, and CDC researchers Carol L. Brosgart, MD Senior Advisor on Science and Policy
More information